Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. A G Dalgleish
  1. Professor of oncology Division of Oncology, Department of Cellular and Molecular Sciences, St George's Hospital Medical School, London SW17 0RE

    EDITOR,—It is easy to sympathise with some of the points on both sides of the argument over whether chemotherapy should be given for solid tumours.1 The nihilistic approach promulgated by G M Mead, however, would lead to no advances in treatment being made. As Mead points out, treatments that might benefit only a small percentage of patients will be sought by most patients—though not by their doctors, as pointed out by Slevin et al.2 The dramatic improvement in …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular